CA
RDY icon

Commerzbank Aktiengesellschaft’s Dr. Reddy's Laboratories RDY Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-43,845
Closed -$331K – 966
2018
Q4 		$331K Sell
43,845
-52,230
-54% -$367K ﹤0.01% 748
2018
Q3 		$665K Sell
96,075
-1,585
-2% -$10.6K 0.01% 638
2018
Q2 		$629K Sell
97,660
-27,185
-22% -$171K 0.01% 615
2018
Q1 		$816K Buy
124,845
+43,435
+53% +$304K 0.01% 576
2017
Q4 		$612K Sell
81,410
-1,965
-2% -$14.2K 0.01% 630
2017
Q3 		$595K Buy
83,375
+810
+1% +$5.82K 0.01% 570
2017
Q2 		$696K Sell
82,565
-1,175
-1% -$9.55K 0.01% 468
2017
Q1 		$672K Sell
83,740
-12,630
-13% -$109K 0.01% 563
2016
Q4 		$873K Sell
96,370
-26,415
-22% -$246K 0.01% 471
2016
Q3 		$1.14M Buy
122,785
+69,955
+132% +$668K 0.02% 414
2016
Q2 		$541K Sell
52,830
-465
-0.9% -$4.26K ﹤0.01% 641
2016
Q1 		$482K Sell
53,295
-13,980
-21% -$125K ﹤0.01% 701
2015
Q4 		$623K Buy
67,275
+37,670
+127% +$413K ﹤0.01% 797
2015
Q3 		$378K Sell
29,605
-6,090
-17% -$75.7K ﹤0.01% 885
2015
Q2 		$395K Buy
+35,695
New +$394K ﹤0.01% 1031
2014
Q3 		– Sell
-48,205
Closed -$416K – 1176
2014
Q2 		$416K Hold
48,205
– – ﹤0.01% 1028
2014
Q1 		$423K Sell
48,205
-660
-1% -$5.74K ﹤0.01% 1012
2013
Q4 		$408K Buy
+48,865
New +$387K ﹤0.01% 1131
2013
Q3 		– Sell
-54,500
Closed -$412K – 1397
2013
Q2 		$412K Buy
+54,500
New +$398K ﹤0.01% 1130

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Commerzbank Aktiengesellschaft's RDY Position: Q1 2019 in Review

Commerzbank Aktiengesellschaft sold out of Dr. Reddy's Laboratories (RDY) in Q1 2019, closing a stake of 43,845 shares — an estimated $331K sold.

Commerzbank Aktiengesellschaft first reported a position in RDY in Q2 2013 and held it in 19 quarters. The position peaked at $1.14M in Q3 2016. 143 funds tracked by Wall St. Rank hold RDY as of Q1 2019.

  • Commerzbank Aktiengesellschaft reported no remaining Dr. Reddy's Laboratories position as of Q1 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 43,845 Dr. Reddy's Laboratories shares in Q1 2019, an estimated $331K.
  • Commerzbank Aktiengesellschaft first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 19 quarters.
  • Commerzbank Aktiengesellschaft's Dr. Reddy's Laboratories position peaked at $1.14M in Q3 2016.
  • 143 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2019, filed 13 May 2019.